Login / Signup
Nivolumab plus ipilimumab: a potential regimen to rewrite treatment guidelines for ESCC.
Yuejun Luo
Nan Sun
Jie He
Published in:
Signal transduction and targeted therapy (2022)
Keyphrases
</>
combination therapy